1265883-88-2

Basic information

• Product Name: (1R,2R,4R)-4-(tert-butyldiphenylsilanyloxy)cyclohexane-1,2-dicarboxylic acid 2-tert-butyl ester
• Synonyms: (1R,2R,4R)-4-(tert-butyldiphenylsilanyloxy)cyclohexane-1,2-dicarboxylic acid 2-tert-butyl ester
• CAS NO: 1265883-88-2
• Molecular Weight: 482.692
• Mol File: 1265883-88-2.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (1R,2R,4R)-4-(tert-butyldiphenylsilanyloxy)cyclohexane-1,2-dicarboxylic acid 2-tert-butyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: (1R,2R,4R)-4-(tert-butyldiphenylsilanyloxy)cyclohexane-1,2-dicarboxylic acid 2-tert-butyl ester(1265883-88-2)
• EPA Substance Registry System: (1R,2R,4R)-4-(tert-butyldiphenylsilanyloxy)cyclohexane-1,2-dicarboxylic acid 2-tert-butyl ester(1265883-88-2)

Safety Data

• Hazardous Substances Data: 1265883-88-2(Hazardous Substances Data)

Upstream product

• 31139-02-3 (1R,6S)-6-methoxycarbonyl-3-cyclohexene-1-carboxylic acid 
• 1265883-85-9 (1R,2R,4R)-4-(tert-butyldiphenylsilanyloxy)cyclohexane-1,2-dicarboxylic acid 2-benzyl ester 1-methyl ester 
• 1265883-86-0 (1R,2R,4R)-4-(tert-butyldiphenylsilanyloxy)cyclohexane-1,2-dicarboxylic acid 1-methyl ester 
• 1265883-87-1 (1R,2R,4R)-4-(tert-butyldiphenylsilanyloxy)cyclohexane-1,2-dicarboxylic acid 2-tert-butyl ester 1-methyl ester 
• 323196-38-9 (1R,2R)-cyclohex-4-ene 1,2-dicarboxylic acid monomethyl ester 
• 1265882-88-9 (1R,2R,4R,5S)-4-iodo-7-oxo-6-oxabicyclo[3.2.1]-octane-2-carboxylic acid methyl ester 
• 1265882-89-0 (1R,2R,5R)-7-oxo-6-oxabicyclo[3,2,1]octane-2-carboxylic acid methyl ester 
• 1265882-90-3 (1R,2R,4R)-4-hydroxy-cyclohexane-1,2-dicarboxylic acid 2-benzyl ester 1-methyl ester 
• 36805-97-7 N,N-dimethylformamide di-tert-butyl acetal 
• 78215-74-4 (1R,2R,4R,5S)-4-iodo-7-oxo-6-oxa-bicyclo[3.2.1]-octane-2-carboxylic acid methyl ester 

Downstream Products

• 1265883-89-3 (1R,2R,4R)-5-(tert-butyldiphenylsilanyloxy)-2-(hex-5-enyl-methylcarbamoyl)cyclohexanecarboxylic acid tert-butyl ester 

Relevant articles and documents

Macrocyclic serine protease inhibitors, pharmaceutical compositions thereof, and their use for treating HCV infections

Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula I, and pharmaceutical compositions and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.

MACROCYCLIC SERINE PROTEASE INHIBITORS USEFUL AGAINST VIRAL INFECTIONS, PARTICULARLY HCV

Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula (Ia) or (Ib), pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.